Puts Purchased on Clinical Data, Inc. (CLDA)

Shares of Clinical Data, Inc. CLDA are lower on the session by 0.10%, currently trading at $30.32. The stock had been moving largely sideways over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short while ago the April $30.00 put was purchased 4,000 times, on the offer, on open interest of 2,916 contracts. Overall put volume is now running at 2.59x the daily average with 83% of all puts traded being purchases on the offer. Clinical Data, Inc. is focused on the development and commercialization of therapeutics, with two compounds in the areas of central nervous system and cardiovascular disorders. The company's late-stage drug candidate is vilazodone, a dual-acting selective and potent serotonin reuptake inhibitor and serotonin receptor 1A (5-HT1A) partial agonist for the treatment of major depressive disorder (MDD).